No Data
No Data
Echo IQ Launches Heart Failure Detection Study With AI
Medical technology company Echo IQ (ASX:EIQ) signed an agreement with St. Vincent's Institute of Medical Research to carry out a clinical study using the firm's proprietary AI algorithm for the automa
Echo IQ Lodges US FDA Application for EchoSolv Market Clearance; Shares Fall 4%
Medical technology company Echo IQ (ASX:EIQ) submitted its US Food and Drug Administration application for market clearance of EchoSolv AS, its artificial intelligence-powered decision support tool to
Echo IQ Secures R&D Tax Rebate for Fiscal Year 2023
Echo IQ (ASX:EIQ) secured a AU$1.3 million rebate from the Australian government's research and development tax incentive scheme for the fiscal year ended June 30, 2023, according to a filing with the
Respiri Signs Deal to Integrate Echo IQ's Cardiovascular Technology to Remote Monitoring System; Shares Fall 4%
Respiri (ASX:RSH) signed an exclusive licensing deal to integrate Echo IQ's (ASX: EIQ) cardiovascular diagnostic analysis technology, EchoSolv, into its remote patient monitoring system in the US, acc
Echo IQ Appoints CEO
AI and medical technology company Echo IQ (ASX:EIQ) named Kimber Rothwell as its new chief executive officer, effective Jan. 29. Rothwell has extensive experience in healthcare technology, according t
EchoIQ Applies for Patent for Heart Failure Algorithm
EchoIQ (ASX:EIQ) applied for a new provisional patent for proprietary Heart Failure algorithm. The algorithm will be incorporated into its EchoSolv program. The Australian operator of software that di
No Data